Atlas Trials

A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers

Clinical trial NCT02202187 · COMPLETED

Trial details

NCT number
NCT02202187
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infections, Respiratory Tract
Start date
2011-09-26
Primary completion
2012-02-15
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.